Health & Medicine

6
facebook twitter google print email
Media Contact:Katie Delach | katie.delach@uphs.upenn.edu | 215-349-5964October 16, 2014

Penn Medicine Researchers Zero in on Psoriasis-Hypertension Link

Patients with more severe psoriasis are also more likely to have uncontrolled hypertension, according to new research by a team at the Perelman School of Medicine at the University of Pennsylvania

facebook twitter google print email
Media Contact:Katherine Unger Baillie | kbaillie@upenn.edu | 215-898-9194November 11, 2014

Collaborative Penn-Dresden Study Blocks Multiple Sclerosis Relapses in Mice

blurb: 
In a new study, researchers from the University of Pennsylvania and co-investigators have identified a key protein that is able to reduce the severity of a disease equivalent to multiple sclerosis in mice.

In multiple sclerosis, the immune system goes rogue, improperly attacking the body’s own central nervous system. Mobility problems and cognitive impairments may arise as the nerve cells become damaged.

facebook twitter google print email
Media Contact:Anna Duerr | anna.duerr@uphs.upenn.edu | 215-349-8369November 5, 2014

Readmission Rates Above Average for Survivors of Septic Shock, Penn Study Finds

blurb: 
Penn Medicine researchers have now shown that while most patients now survive a hospital stay for septic shock, 23 percent will return to the hospital within 30 days, many with another life-threatening condition -- a rate substantially higher than the normal readmission rate at a large academic medical center.

A diagnosis of septic shock was once a near death sentence. At best, survivors suffered a substantially reduced quality of life.

facebook twitter google print email
Media Contact:Katie Delach | katie.delach@uphs.upenn.edu | 215-349-5964November 6, 2014

Penn Study: Olaparib Shows Promise As Treatment Option for Patients with BRCA-Related Cancers

blurb: 
A Penn Medicine study Finds Olaparib shows success in tumor response rate for patients with BRCA-related cancers. The study's results provide promising treatment option and improved survival rates for patients with ovarian, breast, pancreatic and prostate cancers

Olaparib, an experimental twice-daily oral cancer drug, produces an overall tumor response rate of 26 percent in several advanced cancers associated with BRCA1 and BRCA2 mutations, according to new research co-led by the Abramson Cancer Center of the University of Pennsylvania.

facebook twitter google print email
Media Contact:Evan Lerner | elerner@upenn.edu | 215-573-6604November 10, 2014

Penn Center for Innovation Celebrates Launch

WHO:

Amy Gutmann
President, University of Pennsylvania

Michael A. Nutter
Mayor, City of Philadelphia

Dawn Bonnell
Vice Provost for Research

John Swartley
Director, Penn Center for Innovation
Assistant Vice Provost for Research

WHAT:

 Penn Center for Innovation Launch Celebration

WHEN:

Nov. 17, 2014
4 p.m – 6 p.m.

WHERE:

Prince Theater
The Annenberg Center for the Performing Arts
3680 Walnut St.
Philadelphia

ABOUT:

The Penn Center for Innovation, a new initiative that will provide the infrastructure, leadership and resources needed to transfer promising Penn inventions, know-how and related assets into the marketplace for the public good, will be formally launched at an event on Monday, November 17.

Gutmann, Nutter, Bonnell and Swartley will discuss how PCI will accelerate the translation of Penn discoveries and ideas into commercial products, businesses, and services, as well as the role the University plays in the local, national and global entrepreneurial ecosystem. 

Top Penn researchers and members of the business and venture capital community will have the opportunity to meet at a reception to follow. 

Attendance is free and open to the public, but email registration is mandatory.    

facebook twitter google print email
Media Contact:Katherine Unger Baillie | kbaillie@upenn.edu | 215-898-9194October 14, 2014

Penn Graduate Student Attends Prestigious Meeting of Nobel Laureates

blurb: 
It’s not every day that a graduate student gets to meet a Nobel Laureate in her field. But this summer Rianne Esquivel, a fourth-year doctoral candidate in microbiology at the University of Pennsylvania, had the opportunity to meet not just one but 37 Nobel Laureates, all leaders in biomedical sciences.

By Madeleine Stone  @themadstone

facebook twitter google print email
Media Contact:Lee-Ann Donegan | leeann.donegan@uphs.upenn.edu | 215-349-5660October 10, 2014

Penn Medicine Announces Naming of Paul F. Harron, Jr. Lung Center

A $10 million gift to the University of Pennsylvania to name the Paul F. Harron, Jr.

facebook twitter google print email
Media Contact:Katie Delach | katie.delach@uphs.upenn.edu | 215-349-5964October 14, 2014
facebook twitter google print email
Media Contact:Karen Kreeger | karen.kreeger@uphs.upenn.edu | 215-349-5658October 14, 2014

Penn Medicine: New Gene Therapy for "Bubble Boy" Disease Appears to be Safe, Effective

A new form of gene therapy for boys with X-linked severe combined immunodeficiency syndrome (SCID-X1), a life-threatening condition also known as “bubble boy” disease, appears to be both effective and safe, according to an international clinical trial with sites in Boston, Cincinnati, Los Angeles, London, a

facebook twitter google print email
Media Contact:Anna Duerr | anna.duerr@uphs.upenn.edu | 215-349-8369October 14, 2014

Penn Study Evaluates Medical Resident Assessment Tool to Reduce Unnecessary Tests and Treatments

A first-of-its-kind set of questions included in the Internal Medicine In-Training Examination (IM-ITE) illustrates the need to better evaluate resident proficiency in high-value care (HVC), according to a new study published in Annals of